AKYA - Wutah dodolan YoY sajrone 12 wulan kepungkur Akoya Biosciences

Akoya Biosciences revenues rely on grant volumes and biomedical funding. The year-over-year sales trend over the last 12 months (TTM) illustrates this pattern, with the latest value recorded as 31.10. The company is implementing PhenoCycler systems for tumor analysis, creating automated spatial phenotyping complexes that completely eliminate routine manual labor in modern laboratories.
Ringkesan rincian data analitis Akoya (AKYA)

To identify fundamental stability drivers, analyze the year-over-year sales volume growth over the last 12 months, which measures the percentage change in TTM revenue relative to the same period last year to assess business scaling rates. This indicator's trend reflects the market adoption of the innovative PhenoCycler system, confirming the commercial effectiveness of Akoya Biosciences (AKYA) spatial biology technologies within the high-precision oncology immunotherapy segment.